Consultancy for the marketing and promotion of reporting adverse events involving COVID-19 VACCINES or medicines
CARPHA was legally established in July 2011 by an Inter-governmental Agreement (IGA) signed by Heads of Caribbean Governments and began operations in January 2013. CARPHA’s functions encompass the responsibilities of five (5) previously existing regional health institutions. Work in these areas advances the public health agenda in the Region and makes a valuable and coordinated contribution to the knowledge and resources of the international health community.The purpose of this contract is: To strengthen market and safety surveillance systems with attention to planning, passive and active reporting, investigating and analyzing adverse events following immunization (AEFIs) and adverse drug reactions (ADRs). More specifically, the services of a consultant will be contracted to develop and implement a marketing plan, and materials for the promotion of AEFI / ADR reporting, with appropriate translations.
BACKGROUND, OBJECTIVE, SCOPE OF WORK
See attached Terms of Reference for details.
CARPHA invites eligible consultant to indicate their interest in providing the services. Interested consultant must provide information indicating that they are qualified to perform the services (CV, General Experience in in the Field of the assignment, Specific Experience in specific area of expertise).
COSTING AND IMPLEMENTATION
The maximum value of the consultancy is USD $35,000. The intended start date is August, 2022 and the period of implementation of the contract will be Four (4) months.
DEADLINE FOR SUBMITTING EXPRESSIONS OF INTEREST
Expressions of interest must be delivered in English by email to the address below by Wednesday 13 June, 2022 to:
Caribbean Public Health Agency
Mr. Anthony Seunarine
Notice expires at 11:59pm on Monday June 13th, 2022